COMBINATION THERAPY WITH DOFETILIDE AND MEXILETINE FOR ATRIAL FIBRILLATION: INCREASED EFFICACY AND DECREASED QT INTERVAL PROLONGATION

Muhammad Abubakar Shakir,Jacob Reiss,Meghan Buckley,William Surkis,Gan-Xin Yan
DOI: https://doi.org/10.1016/s0735-1097(20)31108-6
IF: 24
2020-01-01
Journal of the American College of Cardiology
Abstract:Dofetilide, a class III antiarrhythmic is indicated for conversion of atrial fibrillation (AF) to sinus rhythm and maintenance of sinus rhythm. Dofetilide works by blocking the repolarizing potassium currents and hence prolongs QT interval. QT prolongation can predispose to serious ventricular
What problem does this paper attempt to address?